📄 Recross-examination of Dr. Robin Cotton (part 1) — Monday, May 15, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\15\RECROSS-EXAMINATION-OF-DR-ROBI.DOC
TRIAL
▲ Day 74 of 167

Recross-examination of Dr. Robin Cotton (part 1)

Witness: Dr. Robin Cotton
Examiner: Peter Neufeld
Called by: Prosecution • Date: Monday, May 15, 1995 • Utterances: 113
Defense attorney Peter Neufeld conducted a brief recross-examination of Cellmark's DNA expert Dr. Robin Cotton, focusing on undermining the comparative degradation analysis Clarke had established on redirect. Neufeld scored two significant points: that items 78 and 56 were not processed alongside the Bundy drops, making Clarke's degradation comparisons inapplicable, and that only two people in Cellmark's entire African-American database had been typed at all five genetic loci used in the case.
1 THE COURT:

All right. Dr. Cotton, why don't you retake the witness stand. All right. Thank you, ladies and gentlemen. Please be seated. All right. Let the record reflect we've been rejoined by all the members of our jury panel. Mr. Neufeld.

2 MR. NEUFELD:

Thank you. Good afternoon again, ladies and gentlemen.

THE JURY: Good afternoon.

RECROSS-EXAMINATION MR. NEUFELD

3 MR. NEUFELD:

Dr. Cotton?

4 DR. COTTON:

Yes.

5 MR. NEUFELD:

Dr. Cotton, on redirect examination, Mr. Clarke asked you a series of questions concerning relative degradations if you will of the different items or some of the different items involved in this case that Cellmark analyzed. Do you recall that?

6 DR. COTTON:

Yes, I do.

7 MR. NEUFELD:

And along with the drops purportedly collected at Bundy, he also asked you about the--about item 78 and item 56. Do you recall that?

8 DR. COTTON:

Yes.

9 MR. NEUFELD:

Now, and I think you said as to item 78, that there seemed to be a fair amount of high molecular weight DNA present; is that correct?

10 DR. COTTON:

I believe that's correct.

11 MR. NEUFELD:

All right. And--and these questions that were put to you by Mr. Clarke were put to you in the context of showing the range of degradation that occurred on these different samples. Do you recall that?

12 DR. COTTON:

Yes. You're right.

13 MR. NEUFELD:

Now, are you aware, Dr. Cotton, of the fact that item 78 wasn't even processed by LAPD on either June 13th or June 14th?

14 DR. COTTON:

No. I have--I don't know when it was processed by LAPD.

15 MR. NEUFELD:

Would you agree as an expert that if in fact--in fact item 78, as a collected swatch, didn't even arrive at the Los Angeles Police Department on the days when they were initially processing these items, would that change your opinion as to the--as to the consequences of the variety of degradation on these samples?

16 MR. CLARKE:

Objection. Beyond the scope as to these items.

17 THE COURT:

Overruled.

18 DR. COTTON:

Well, if it wasn't processed at the same time, then all the various hypotheticals about--that I was discussing wouldn't be applicable because it wasn't even there.

KEY QUOTE
19 MR. NEUFELD:

And also, you were asked about item 56. And, Dr. Cotton, were you aware of the fact that when extractions of DNA samples were done at LAPD on the 14th, that item 56 was not included in that group?

20 DR. COTTON:

No. I--again, I don't know what was done at LAPD at any particular day.

21 MR. NEUFELD:

Now, again, doctor--

22 MR. CLARKE:

I'm sorry. I think the witness was cut off. She may have been finished.

23 THE COURT:

I think she was finished.

24 MR. NEUFELD:

I apologize, Dr. Cotton.

25 DR. COTTON:

That's all I had to say.

26 THE COURT:

But we're trying to finish.

27 MR. NEUFELD:

Dr. Cotton, again, just as I asked you with regard to item 78, assume hypothetically that item 56 was--did not go through the extraction or the processing procedures for DNA typing that the Bundy drops went through on the morning of the 14th. Again, would you draw that same distinction, that those hypotheticals wouldn't apply?

28 MR. CLARKE:

Same objection. Beyond the scope.

29 THE COURT:

Overruled.

30 DR. COTTON:

Yes, I would.

31 MR. NEUFELD:

I think the one thing that you did say on redirect examination is that all those samples that purportedly originate from the Bundy walkway were either very degraded or moderately degraded; is that correct?

32 DR. COTTON:

Yes.

33 MR. NEUFELD:

And you had mentioned by the way that--I'm sorry. Withdrawn. On cross-examination, initially, you did say that the one table that you could rely on in the NRC report was the table 1-1, which dealt with the DNA content of biological samples. Do you recall that?

34 DR. COTTON:

Yes, I do.

35 MR. NEUFELD:

And would you agree, Dr. Cotton, that in that table in the NRC report, it states that the amount of DNA present in a milliliter of blood is somewhere between 20--

36 MR. CLARKE:

Objection. Excuse me. Hearsay, your Honor.

37 THE COURT:

Sustained. Exceeds the scope of the redirect.

38 MR. NEUFELD:

Your Honor--

39 THE COURT:

The question has to be directed toward the amount of DNA present in degraded samples. That was what was asked on the redirect.

40 MR. NEUFELD:

That's what I am going to, but this is a preliminary foundation question--

41 THE COURT:

Keep going.

42 MR. NEUFELD:

Can I ask that question then?

43 THE COURT:

Rephrase the question.

44 MR. NEUFELD:

Okay. And doesn't the table state, Dr. Cotton--

45 MR. CLARKE:

Again, objection. Hearsay.

46 THE COURT:

Overruled.

47 MR. NEUFELD:

--Dr. Cotton, that there are approximately 20,000 to 40,000 nanograms of DNA in a milliliter of blood?

48 DR. COTTON:

That's my recollection, yes.

49 MR. NEUFELD:

And are you aware, Dr. Cotton, that there are approximately 20 drops of blood in a milliliter of blood?

50 DR. COTTON:

No. Drops aren't too good in terms of quantitation.

51 MR. NEUFELD:

Well, are you--are you--would you agree that as a rough estimate, that there are approximately 20 drops of blood in a milliliter of blood?

52 DR. COTTON:

I don't really--I don't really know. And when you're--when you're using something, the--the opening of that instrument, like you have a pipetter tip with a big opening versus a little opening, you have different size drops. So I would rather work in some other quantitative sense than--than drops.

53 MR. NEUFELD:

Have you reviewed any literature which suggested that there were approximately 20 drops of blood in a milliliter of blood?

54 DR. COTTON:

Well, if I ever have, I wouldn't remember now. So I'm sorry.

55 MR. NEUFELD:

Can you estimate based on your own experience approximately how many nanograms of blood--excuse me--how many nanograms of DNA are in a drop of blood, an average drop of blood?

56 DR. COTTON:

No.

57 MR. NEUFELD:

Can you give a range?

58 DR. COTTON:

Well, if I got--not easily.

59 MR. NEUFELD:

Well, to the best of your ability, doctor, what would that range be?

60 DR. COTTON:

I don't think I can give you a range given that I'm--what I'm telling you is that I don't really know what the volume is in a drop and, therefore, I'm hesitant to try to carry that any further.

61 MR. NEUFELD:

All right. Dr. Cotton, but you would agree that at least as to all these samples from the Bundy walkway, they are either experienced moderate or extreme degrees of degradation; is that right?

62 DR. COTTON:

Yes, I do.

63 MR. NEUFELD:

And you can not tell, Dr. Cotton, when you look at the yield gel or the slot blot as to whether the degraded or the remaining DNA that you see is there because it's from the original source or it's there as a result of cross-contamination; isn't that correct?

64 DR. COTTON:

Yes. That's correct.

65 MR. NEUFELD:

I believe you also said, Dr. Cotton, that the role that the plastic bags play in preventing cross-contamination is that obviously if a sample is in one plastic bag and another sample is in a second plastic bag, that they're not going to cross-contaminate while in that status; is that right?

66 DR. COTTON:

Yes.

67 MR. NEUFELD:

But would you agree, Dr. Cotton, that once the samples are removed from the plastic bags, the plastic bags are no longer a deterrent to cross-contamination? Isn't that right?

68 DR. COTTON:

Yes. That's of course right.

69 MR. NEUFELD:

And, Dr. Cotton, when you're referring to the reagent blank control, lighting up two DNA dots in this particular case, I believe you said that there's some discretion left to the Ph.D.s in the laboratory to decide whether or not to retest; is that correct?

70 DR. COTTON:

Or to report or to do some other options that might be available.

71 MR. NEUFELD:

Isn't it a fact, Dr. Cotton, that the protocol states that when the results--I'm sorry--that when a questionable result is reported, that it's to be interpreted by the Ph.D.s in the laboratory?

72 DR. COTTON:

Yes.

73 MR. NEUFELD:

And would you agree, Dr. Cotton, that with respect to the presence of those two dots, those two DNA dots on the reagent blank, their presence on those reagent blanks was not questioned?

74 MR. CLARKE:

Objection. Vague.

75 THE COURT:

Overruled.

76 DR. COTTON:

No. It's obviously there. I mean it was recorded by the analyst who read the strips. And if I remember correctly, you can just barely see it in the photos, but you can see it. So it's clearly there.

77 MR. NEUFELD:

And it was clearly there by both analysts who reviewed that data, correct?

78 DR. COTTON:

Yes.

79 MR. NEUFELD:

And, Dr. Cotton, you were also talking about how your database has approximately 600 people in it; is that correct?

80 DR. COTTON:

If you add up all the three racial groups--you know, taking into account you don't have the same number of people in each probe, it's I think between 5- and 600.

81 MR. NEUFELD:

And your database includes five different genetic loci, is that right, for the RFLPs?

82 DR. COTTON:

Yes, it does.

83 MR. NEUFELD:

I asked you, if you recall, on cross-examination initially if you could find out for us as to how many people in that African American database you actually ran all five genetic markers on. Do you recall me asking that question?

84 DR. COTTON:

Yes, I do.

85 MR. NEUFELD:

And I believe you said you could find that out overnight; is that right?

86 DR. COTTON:

That's right.

87 MR. NEUFELD:

And, Dr. Cotton, how many members of your African American database have been subjected to all five genetic loci in this case?

88 DR. COTTON:

Well, somebody took the sheet from me.

89 MR. NEUFELD:

I'm sorry.

90 DR. COTTON:

It's not very many.

91 MR. NEUFELD:

Is it two?

92 DR. COTTON:

Yes. Of all the blacks, there are only two that are across all five.

KEY QUOTE
93 MR. NEUFELD:

Two people in the entire African-American database have been subjected to all five loci in your laboratory; is that right?

94 DR. COTTON:

Well, that's true. It's--

95 MR. NEUFELD:

Now, Dr.--

96 MR. CLARKE:

I'm sorry. Could the witness finish the answer, please?

97 THE COURT:

Yes.

98 DR. COTTON:

I don't think that's a critical feature.

99 MR. NEUFELD:

Okay. Dr. Cotton, you gave an answer before on the subject of--of the assumption of independence of these different genetic traits. Do you recall that?

100 DR. COTTON:

Yes, I do.

101 MR. NEUFELD:

And would you agree, Dr. Cotton, that that issue, okay, as to that assumption of independence is a question that arises in the or was in the province of population geneticists?

102 DR. COTTON:

Yes.

103 MR. NEUFELD:

And, Dr. Cotton, do you consider yourself an expert in the field of population genetics?

104 DR. COTTON:

No. I'm certainly not an academics expert in the field of population genetics. I know a lot about it as it pertains to forensic DNA typing, but there's much more to know beyond what I know.

KEY QUOTE
105 MR. NEUFELD:

And so you wouldn't consider yourself an expert in that field?

106 DR. COTTON:

No. I don't think so.

107 MR. NEUFELD:

And, Dr. Cotton, you said at the very close of the redirect examination that these statistics that you put up on the board only tell you about the rarity of a particular profile; is that correct?

108 DR. COTTON:

Yes. That's what I said.

109 MR. NEUFELD:

And so would you agree, Dr. Cotton, that those statistics tell you nothing about the probability of a false positive at LAPD?

110 DR. COTTON:

Yes. Of course that's right.

KEY QUOTE
111 MR. NEUFELD:

No further questions. One second.

112 (Discussion held off the record between Defense counsel.)
113 MR. NEUFELD:

No further questions, your Honor.

Temperature

tense

Key Quotes (4)

Dr. Robin Cotton
Well, if it wasn't processed at the same time, then all the various hypotheticals about--that I was discussing wouldn't be applicable because it wasn't even there.
Concession that Clarke's redirect comparison of degradation across samples collapses if items 78 and 56 weren't processed contemporaneously with the Bundy drops.
Dr. Robin Cotton
Yes. Of all the blacks, there are only two that are across all five.
Devastating admission that the African-American reference database used for statistical frequency calculations had only two individuals typed at all five RFLP loci, severely undermining the reliability of the population statistics.
Dr. Robin Cotton
No. I'm certainly not an academics expert in the field of population genetics. I know a lot about it as it pertains to forensic DNA typing, but there's much more to know beyond what I know.
Cotton disavows expertise in population genetics, undercutting her own statistical conclusions which rest on population genetics assumptions.
Dr. Robin Cotton
Yes. Of course that's right.
Concedes that the frequency statistics say nothing about the probability of a false positive at LAPD — the closing question Neufeld needed to land.

Evidence (5)

Informal
Item 78 — collected swatch, timing of LAPD processing
discussed — Neufeld established it was not processed on June 13th or 14th alongside Bundy drops
Informal
Item 56 — not included in LAPD extraction/processing group on June 14th
discussed — same point as item 78, undermining Clarke's degradation comparison
Informal
NRC report Table 1-1, DNA content of biological samples (nanograms per milliliter of blood)
referenced — hearsay objection sustained initially, then overruled on rephrasing
Informal
Reagent blank control showing two DNA dots
discussed — Cotton confirmed both analysts observed and recorded the dots without questioning them
Informal
Cellmark African-American RFLP database (~500-600 individuals across three racial groups)
challenged — only two African-American individuals typed at all five loci

Notable Exchanges (3)

Peter NeufeldDr. Robin Cotton
Neufeld pressed Cotton on how many drops of blood are in a milliliter to establish a nanogram-per-drop figure; Cotton deflected repeatedly, saying drop volume varies by instrument opening and she couldn't give a range.
strategic — Neufeld probing for a concession Cotton refused to make
Peter NeufeldDr. Robin Cotton
Cotton admitted only two people in the African-American database were typed at all five loci, then immediately added 'I don't think that's a critical feature' before being cut off.
revealing — the database limitation was a significant blow, and Cotton's attempted minimization was interrupted
George ClarkeLance A. Ito
Clarke interjected to note Cotton may have been cut off mid-answer; Ito confirmed she was finished. A small procedural courtesy that briefly interrupted Neufeld's rhythm.
procedural

Light Moments (1)

Dr. Robin Cotton
Cotton admitted she couldn't find the database sheet: 'Well, somebody took the sheet from me.' Then acknowledged only two African-Americans were in the full five-loci database.

Credibility Attacks (3)

⚔ Dr. Robin Cotton
exposing methodological limitation
Neufeld established that only two African-Americans in Cellmark's database were typed at all five RFLP loci, undermining the statistical foundation for the frequency estimates Cotton provided.
⚔ Dr. Robin Cotton
eliciting disavowal of expertise
Cotton conceded she is not an expert in population genetics, the field underlying the independence assumptions used to calculate the match statistics she testified to.
⚔ Prosecution's redirect comparison
factual undermining
Neufeld established that items 78 and 56 were not processed contemporaneously with the Bundy drops, making Clarke's comparative degradation analysis inapplicable by Cotton's own admission.

Witness Demeanor

Cotton was measured and technical throughout, deflecting the drops-per-milliliter question by retreating to scientific precision about instrument variability.
Attempted to minimize the two-person database admission with 'I don't think that's a critical feature' but was cut off before elaborating.

Objections

7 objections (1 sustained, 5 overruled)
Proceeding 6048 • 113 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 15, 1995 📄 Recross-examination of Dr. Rob
MAY 15, 1995 KRT DvH TD